These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia. Matthai WH Semin Thromb Hemost; 1999; 25 Suppl 1():57-60. PubMed ID: 10357153 [TBL] [Abstract][Full Text] [Related]
3. Anticoagulation strategies for patients undergoing percutaneous coronary intervention: unfractionated heparin, low-molecular-weight heparins, and direct thrombin inhibitors. Kokolis S; Cavusoglu E; Clark LT; Marmur JD Prog Cardiovasc Dis; 2004; 46(6):506-23. PubMed ID: 15224257 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Mahaffey KW Curr Cardiol Rep; 2001 Sep; 3(5):362-70. PubMed ID: 11504572 [TBL] [Abstract][Full Text] [Related]
5. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Lewis BE; Hursting MJ Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457 [TBL] [Abstract][Full Text] [Related]
6. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia. Dhillon S Am J Cardiovasc Drugs; 2009; 9(4):261-82. PubMed ID: 19655821 [TBL] [Abstract][Full Text] [Related]
10. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Lewis BE; Matthai WH; Cohen M; Moses JW; Hursting MJ; Leya F; Catheter Cardiovasc Interv; 2002 Oct; 57(2):177-84. PubMed ID: 12357516 [TBL] [Abstract][Full Text] [Related]
11. Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome. Lewis BE; Iaffaldano R; McKiernan TL; Rao L; Donkin J; Wallenga JM Cathet Cardiovasc Diagn; 1996 Jun; 38(2):206-9. PubMed ID: 8776531 [TBL] [Abstract][Full Text] [Related]
17. A guide to drug use during percutaneous coronary intervention. Choo JK; Young JJ; Kereiakes DJ Drugs; 2002; 62(18):2589-601. PubMed ID: 12465999 [TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy. Walenga JM; Bick RL Med Clin North Am; 1998 May; 82(3):635-58. PubMed ID: 9646784 [TBL] [Abstract][Full Text] [Related]
19. Heparin-induced thrombocytopenia: a ten-year retrospective. Warkentin TE Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268 [TBL] [Abstract][Full Text] [Related]
20. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia. Jeske WP; Walenga JM Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]